Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma

被引：0
|
作者：
Long Shu
Jun Tang
Shuang Liu
Yongguang Tao
机构：
[1] Hunan Cancer Hospital,Hunan Key Laboratory of Cancer Metabolism, The Affiliated Cancer Hospital of Xiangya School of Medicine
[2] Central South University,NHC Key Laboratory of Carcinogenesis (Central South University), Cancer Research Institute, School of Basic Medicine
[3] Central South University,Department of Oncology, Institute of Medical Sciences, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
[4] Central South University,Key Laboratory of Carcinogenesis and Cancer Invasion, Department of Pathology, Xiangya Hospital, School of Basic Medicine
[5] Ministry of Education,Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, Department of Thoracic Surgery, Second Xiangya Hospital
[6] Central South University,undefined
[7] Central South University,undefined
来源：
Cellular Oncology | 2024年 / 47卷
关键词：
Plasma cells; Lung adenocarcinoma; Machine learning; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：555 / 571
页数：16
相关论文
共 50 条
  • [41] Identification of Six-Gene Signatures in Lung Adenocarcinoma and Establishment of Nomogram Model for Prognosis
    Xing, Yingru
    Zhou, Jiawei
    Mu, Min
    Zhang, Xin
    Li, Danting
    Liu, Yafeng
    Xie, Jun
    Hu, Wanfa
    Zhang, Lijun
    Wu, Jing
    Hu, Dong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 39 - 40
  • [42] Cell-in-Cell Structures in Lung Adenocarcinoma Associate With a Poor Prognosis
    Mackay, H. L.
    Moore, D. A.
    Muller, P. A. J.
    Le Quesne, J. C.
    JOURNAL OF PATHOLOGY, 2016, 240 : 30 - 30
  • [43] SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
    Chen, Zhike
    Yang, Jian
    Tang, Lijuan
    Sun, Xue
    Li, Yu
    Sheng, Ziqing
    Ding, Hao
    Xu, Chun
    Tong, Xin
    Zhao, Jun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [44] Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
    Xiaoqing Ma
    Zilin Deng
    Zhen Li
    Ting Ma
    Guiqing Li
    Cuijia Zhang
    Wentao Zhang
    Jin Chang
    Cancer Cell International, 23
  • [45] A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA
    Wang, Ke
    Liu, Ying
    Lu, Guanzhong
    Xiao, Jinrong
    Huang, Jiao
    Lei, Lin
    Peng, Ji
    Li, Yangkai
    Wei, Sheng
    CANCER MEDICINE, 2022, 11 (01): : 281 - 294
  • [46] An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
    Xu, Liexi
    Huang, Zhengrong
    Zeng, Zihang
    Li, Jiali
    Xie, Hongxin
    Xie, Conghua
    FRONTIERS IN GENETICS, 2022, 13
  • [47] Neurotransmitter release cycle-related genes predict the prognosis of lung adenocarcinoma
    Li, Han
    Ge, You
    Wang, Zemin
    Liu, Yangyang
    Wei, Pingmin
    MEDICINE, 2022, 101 (36) : E30469
  • [48] Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
    Lv, Yanju
    Xiao, Yajie
    Cui, Xiaoli
    Luo, Haitao
    Xu, Long
    FRONTIERS IN GENETICS, 2022, 13
  • [49] Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
    Ma, Xiaoqing
    Deng, Zilin
    Li, Zhen
    Ma, Ting
    Li, Guiqing
    Zhang, Cuijia
    Zhang, Wentao
    Chang, Jin
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [50] Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma
    Jiang, Wei
    Xu, Zhanyu
    Huang, Liuliu
    Qin, Fanglu
    Yuan, Liqiang
    Sun, Yu
    Qin, Junqi
    Deng, Kun
    Zheng, Tiaozhan
    Long, Xiaomao
    Li, Shikang
    BMC MEDICAL GENOMICS, 2023, 16 (01)
12345